Services

Professional and Cost-Saving Solutions

AI-Assisted Directed Evolution

Creative Enzymes combines machine learning with directed evolution to accelerate enzyme engineering while reducing screening burden. Our platform replaces random mutagenesis with intelligent library design, predicting high-impact mutations and prioritizing variants before they reach the bench. The result is faster convergence on optimized biocatalysts with fewer experimental cycles and lower resource consumption.

AI-Guided Directed Evolution

Traditional Directed Evolution Limitations

Directed evolution faces a fundamental scaling problem: library size explosion. Targeting five positions with all 20 amino acids generates 3.2 million combinations—far beyond practical screening capacity. Researchers must either constrain diversity artificially or accept that most variants will never be evaluated.

Additional limitations compound this challenge:

Low Hit Rates

Independent randomization misses synergistic interactions between positions.

Epistasis Blindness

Independent randomization misses synergistic interactions between positions.

Property Trade-Offs

Activity-enhancing mutations frequently compromise stability or expression without pre-screening.

Experimental Cost

Large libraries demand disproportionate resources relative to progress.

These limitations motivate a computational layer that narrows the search space intelligently before experimental commitment.

ML-Assisted Directed Evolution Platform

Our platform integrates three ML-driven modules that transform library design from random to rational:

Smart Library Design

Identification of mutation hotspots with highest probability of functional impact using coevolutionary statistics, structural flexibility metrics, and activity-stability trade-off predictors. Libraries are sized to experimental capacity while maximizing coverage of predicted beneficial diversity.

Variant Prioritization

ML scoring of individual and combinatorial mutations to rank variants by predicted improvement in the target property. Ensembles of sequence-based and structure-based predictors calibrate confidence and flag uncertain predictions for experimental resolution.

Reduced Screening Burden

Focused libraries containing 1023 variants replace traditional libraries of 1069 members, concentrating screening effort on computationally pre-qualified candidates. Hit rates improve proportionally, and iterative learning refines predictions cycle by cycle.

The platform operates across enzyme classes and optimization targets, from single-property enhancement to multi-objective balancing.

Workflow

AI-Guided Directed Evolution Workflow

1. Parent Enzyme Characterization: sequence, structure (if available), kinetic profile, and known limitations. Baseline data calibrate model expectations and define optimization objectives.

2. Mutation Modeling: Computational identification of hotspot positions and beneficial substitution probabilities. Structural analysis maps active-site geometry, dynamic regions, and stability-determining contacts. ML models predict mutation effects on target properties.

3. ML Ranking: Ensemble scoring ranks mutations and combinations by predicted improvement magnitude. Top-ranked variants are selected for library inclusion; borderline predictions are flagged for tiered testing.

4. Focused Library: Synthesis of 50–500 variants representing the highest-confidence designs. Library composition balances exploration (diverse mutation types) with exploitation (high-scoring combinations).

5. Screening: Standardized assays measure target properties under relevant conditions. Variants are benchmarked against parent performance and evaluated for unintended trade-offs.

6. Learning Iteration: Screening results refine ML model weights, update hotspot definitions, and inform the next design cycle. Typically, 3–4 iterations converge on variants exceeding project targets.

Subservices

Our service is organized into three optimization tracks that can be pursued independently or in combination:

Service Description Price
AI-Guided Mutant Library Design Computational hotspot identification and library composition optimization. Deliverables include ranked mutation lists, predicted effect magnitudes, and synthesized variant libraries ready for screening. Inquiry
AI-Assisted Screening & Variant Prediction ML-driven prioritization of variants from existing libraries or natural diversity panels. Ideal for projects with pre-constructed libraries requiring intelligent down-selection, or for mining genomic diversity to identify naturally occurring improved variants.
AI-Integrated DBTL Workflows End-to-end Design-Build-Test-Learn cycles with ML models updated iteratively from experimental feedback. Includes full project management from parent enzyme characterization through optimized variant delivery.

Related Directed Evolution Services

Our AI-assisted directed evolution platform can be integrated with traditional directed evolution workflows, including mutant library construction, random and site-directed mutagenesis, high-throughput screening, and iterative enzyme optimization for accelerated variant engineering.

Case Examples

Machine Learning-Assisted Directed Evolution for Chiral Biocatalysis

An overview of obtaining high-diastereoselectivity mutants for tetrabenazine using traditional directed evolution and machine learning-assisted directed evolution Figure 1. An overview of obtaining high-diastereoselectivity mutants for tetrabenazine using traditional directed evolution and machine learning-assisted directed evolution. (Huang et al., 2024)

This study evaluated machine learning-assisted directed evolution as a faster strategy for engineering biocatalysts used in chiral pharmaceutical synthesis. Using the ketoreductase BsSDR10 from Bacillus subtilis as a model enzyme, researchers compared traditional directed evolution with machine learning-guided optimization for the stereoselective reduction of tetrabenazine. Both approaches successfully identified enzyme variants with significantly improved diastereoselectivity toward desired dihydrotetrabenazine isomers. The optimized biocatalytic process was successfully scaled up, achieving a 40.7% isolated yield and 91.3% diastereoselectivity for the target product. The study highlights the ability of machine learning to accelerate protein engineering, efficiently explore larger sequence spaces, and support the development of highly selective enzymes for pharmaceutical manufacturing.

FAQs

  • Q: How does this differ from traditional directed evolution?

    A: Traditional approaches rely on random mutagenesis and high-throughput screening of millions of variants. Our platform computationally pre-screens mutations, reducing library sizes by 100–1000× while improving hit rates and accelerating convergence.
  • Q: What if I don't have a crystal structure?

    A: Homology models are routinely used and sufficient for most applications. Structural information improves prediction accuracy but is not mandatory.
  • Q: How many variants are in a typical focused library?

    A: 50–500 variants, depending on project scope, screening capacity, and optimization target complexity.
  • Q: Can you optimize multiple properties simultaneously?

    A: Yes. Multi-objective scoring balances competing targets through Pareto optimization, with explicit quantification of trade-offs.
  • Q: What is the typical timeline?

    A: 8–12 weeks per DBTL cycle. Most projects achieve target performance within 3–4 cycles.
  • Q: Can I integrate this with your discovery services?

    A: Yes. Enzymes identified through AI-Guided Enzyme Discovery can transition directly into directed evolution campaigns, creating a seamless pipeline from sequence identification to optimized biocatalyst.

References:

  1. Huang C, Zhang L, Tang T, et al. Application of directed evolution and machine learning to enhance the diastereoselectivity of ketoreductase for dihydrotetrabenazine synthesis. JACS Au. 2024;4(7):2547-2556. doi:10.1021/jacsau.4c00284

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.